8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit June 26-28, 2017 at San Diego, USA

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit June 26-28, 2017 at San Diego, USA

Conferenceseries LLC invites all the participants across the globe to attend the “8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit,” slated on June 26-28, 2017 at San Diego, USA.

BABE 2017 Conference which is an International Pharma Marketing Industry Conference is a scientific platform to meet fellow key decision makers all-around the Academic Institutions, Healthcare Institutes, Pharmaceutical, Biotech, CROs supply chain, Logistics practitioners making the congress a perfect platform to share experience, foster collaborations through the research talks & presentations to put forward many thought provoking strategies. It’s a perfect stage to brainstorm, discover new ideas, search for new skills and a platform to show your capabilities and discoveries to the world. BABE 2017 will be one of the outstanding Bioavailability and Bioequivalence Conferences.

Track 1: Clinical Trials :

In a clinical trial, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or changes to participants’ behaviour, such as diet. Clinical trials may compare a new medical approach to a standard one that is already available, to a placebo that contains no active ingredients, or to no intervention. Some clinical trials compare interventions that are already available to each other. When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives (including no intervention). The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. Preclinical trials are early experiments performed in the lab, prior to being tested in humans. This early research helps to identify potential treatments that are unsafe or ineffective. Clinical trials used in drug development are sometimes described by phase. These phases are defined by the Food and Drug Administration (FDA).

FOR MORE DETAILS AND REGISTRATION FOLLOW THE LINK GIVEN BELLOW:

bioavailability-bioequivalence.pharmaceuticalconferences.com



Leave a Reply

Your email address will not be published. Required fields are marked *